HARVARD BIOSCIENCE INC — Director's Dealing 2025

Jan 3, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2024-12-31

Reporting Person: Green James W (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-12-31	Common Stock	D	145365	—	Disposed	2883501	Direct

Footnotes

F1: Represents forfeiture of performance-based restricted stock units ("RSUs") granted to the Reporting Person on March 1, 2022 based on the final determination of the applicable performance conditions.

F2: Includes (a) 117,713 RSUs that will vest on December 29, 2025, (b) 214,797 RSUs that will vest in three equal installments on March 19, 2025, 2026 and 2027, (c) 554,407 RSUs with performance based vesting conditions and (d) 1,996,584 shares of common stock beneficially owned by the Reporting Person.